Preparation and in vivo biotransformation of curcumin micelles

Chinese Pharmaceutical Journal

Volumn 45, Issue 21, 2010, Pages 1639-1643

  Lei, Bo Kai ^a,b   Zhang, Can ^c   Jin, Fang ^a  

^a SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY   (China)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Biotransformation; Conjugate; Curcumin; Micelle

Indexed keywords

ACETONITRILE; ASCORBIC ACID; CURCUMIN; WATER;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STABILITY; DRUG TRANSFORMATION; ENZYME DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MICELLE; NONHUMAN; PARTICLE SIZE; RAT; SUSPENSION; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 78649895846     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. NAVNEET D, BHARAT A, ROBERT N, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer[J]. Clin Cancer Res, 2008, 14(14): 4491-4499.
2. PREETHA A, AJAIKUMAR K, ROBERT N, et al. Bioavailability of curcumin: problems and promises[J]. Mol Pharmaceutics, 2007, 4(6): 807-818.
3. ZHANG C, QU G, SUN Y, et al. Biological evaluation of N-octyl-O-sulfate chitosan as a new nanocarrier of intravenous drugs[J]. Eur J Pharm Sci, 2008, 33(4-5): 415-423.
4. CUI J, ZHAI G X, LOU H X. Preparation and characteristics of curcumin microemulsion[J]. Chin Pharm J, 2005, 40(24): 1877-1880.
5. BIJI K, ANIL S, HIROYUKI M, et al. Improving the solubility and pharmacological efficacy of curcumin by heat treatment[J]. Assay Drug Dev Technol, 2007, 5(4): 567-576.
6. WANG Y J, PAN M H, CHENG A L, et al. Stability of curcumin in buffer solutions and characterization of its degradation products[J]. J Pharm Biomed Anal, 1997, 15(12): 1867-1876.
7. SANKAR M. Binding and stability of curcumin in presence of bovine serum albumin[J]. J Surface Sci Technol, 2007, 23(3-4): 91-110.
8. ONOUE S, TAKAHASHI H, KAWABATA Y, et al. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability[J]. J Pharm Sci, 2010, 99(4): 1871-1881.
9. MUKERJEE A, VISHWANATHA J K. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy[J]. Anti Cancer Res, 2009, 29(10): 3867-3875.
10. PAN M H, HUANG T M, LIN J K. Biotransformation of curcumin through reduction and glucuronidation in mice[J]. Drug Metab Dispos, 1999, 27(4): 486-494.
11. ASAI A, MIYAZAWA T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma[J]. Life Sci, 2000, 67(23): 2785-2793.
12. CHRISTOPHER I, DONALD J, SAMANTHA O, et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine[J]. Cancer Epidemiol Biomarkers Prev, 2002 11(1): 105-111.